Literature DB >> 8238466

Alterations in brain hexokinase activity associated with heart failure in rats.

K P Patel1, P L Zhang, T L Krukoff.   

Abstract

This study examined the activity of discrete regions of the brain as assessed with histological localization and photodensitometric quantification of the metabolic enzyme hexokinase in a group of rats with coronary occlusion (HF) and in sham-operated control rats. Three weeks after surgery, the mean left ventricular end diastolic pressure and right atrial pressure were elevated, and left ventricular peak systolic pressure was decreased in the HF group compared with the sham group; these findings are also observed during heart failure. In addition, histological data indicated that there was a 37.6 +/- 2.8% outer and 40.8 +/- 3.1% inner infarct of the myocardium in the group of rats with HF (n = 6). Rats in the control group had no observable damage to the myocardium (n = 6). Accompanying these symptoms of heart failure were significant increases in hexokinase activity in the parvocellular (pPVN, 16.3%) and magnocellular (mPVN, 17.6%) divisions of the paraventricular nucleus of the hypothalamus, and in the locus ceruleus (LC, 17.1%). No changes in hexokinase activity were observed in the median preoptic area, supraoptic nucleus (SON), subfornical organ, or posterior hypothalamus. These results reinforce the idea that heart failure (with coronary occlusion) is associated with changes in specific areas in the brain and that metabolic alterations in the pPVN, mPVN, and LC are likely related to alterations in vasopressin production, blood volume regulation, and sympathoexcitation observed in the heart failure state.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238466     DOI: 10.1152/ajpregu.1993.265.4.R923

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  35 in total

1.  Gene transfer of neuronal nitric oxide synthase to the paraventricular nucleus reduces the enhanced glutamatergic tone in rats with chronic heart failure.

Authors:  Hong Zheng; Xuefei Liu; Yifan Li; Neeru M Sharma; Kaushik P Patel
Journal:  Hypertension       Date:  2011-10-03       Impact factor: 10.190

2.  Reduction in synaptic GABA release contributes to target-selective elevation of PVN neuronal activity in rats with myocardial infarction.

Authors:  Tae Hee Han; Kiho Lee; Jin Bong Park; Dongchoon Ahn; Jae-Hyeong Park; Dae-Yong Kim; Javier E Stern; So Yeong Lee; Pan Dong Ryu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-17       Impact factor: 3.619

3.  Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II.

Authors:  Neeru M Sharma; Hong Zheng; Parmender P Mehta; Yi-Fan Li; Kaushik P Patel
Journal:  Cardiovasc Res       Date:  2011-08-10       Impact factor: 10.787

4.  Chronic AT1 receptor blockade normalizes NMDA-mediated changes in renal sympathetic nerve activity and NR1 expression within the PVN in rats with heart failure.

Authors:  Allison C Kleiber; Hong Zheng; Neeru M Sharma; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

Review 5.  Role of paraventricular nucleus in mediating sympathetic outflow in heart failure.

Authors:  K P Patel
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

6.  Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure.

Authors:  Allison C Kleiber; Hong Zheng; Harold D Schultz; Jacob D Peuler; Kaushik P Patel
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-02       Impact factor: 3.619

Review 7.  The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction.

Authors:  Alastair V Ferguson; Kevin J Latchford; Willis K Samson
Journal:  Expert Opin Ther Targets       Date:  2008-06       Impact factor: 6.902

8.  Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice.

Authors:  Megan Beauchemin; Ramaz Geguchadze; Anyonya R Guntur; Kathleen Nevola; Phuong T Le; Deborah Barlow; Megan Rue; Calvin P H Vary; Christine W Lary; Katherine J Motyl; Karen L Houseknecht
Journal:  Pharmacol Res       Date:  2019-12-23       Impact factor: 7.658

Review 9.  Role of the hypothalamic PVN in the regulation of renal sympathetic nerve activity and blood flow during hyperthermia and in heart failure.

Authors:  Emilio Badoer
Journal:  Am J Physiol Renal Physiol       Date:  2010-02-10

Review 10.  Integration of renal sensory afferents at the level of the paraventricular nucleus dictating sympathetic outflow.

Authors:  Hong Zheng; Kaushik P Patel
Journal:  Auton Neurosci       Date:  2016-08-06       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.